O'Toole S - Search Results

1

Epitope presentation is an important determinant of the utility of antigens identified from protein arrays in the development of autoantibody diagnostic assays.

Murphy MA, O'Connell DJ, O'Kane SL, O'Brien JK, O'Toole S, Martin C, Sheils O, O'Leary JJ, Cahill DJ. Murphy MA, et al. J Proteomics. 2012 Aug 3;75(15):4668-75. doi: 10.1016/j.jprot.2012.02.031. Epub 2012 Mar 5. J Proteomics. 2012. PMID: 22415278 Clinical Trial.

2

Oestrogen regulated gene expression in normal and malignant endometrial tissue.

O'Toole SA, Dunn E, Sheppard BL, Sheils O, O'Leary JJ, Wuttke W, Seidlova-Wuttke D. O'Toole SA, et al. Maturitas. 2005 Jun 16;51(2):187-98. doi: 10.1016/j.maturitas.2004.07.009. Maturitas. 2005. PMID: 15917160

3

Analysis of DNA in endometrial cancer cells treated with phyto-estrogenic compounds using comparative genomic hybridisation microarrays.

O'Toole SA, Sheppard BL, Sheils O, O'Leary JJ, Spengler B, Christoffel V. O'Toole SA, et al. Planta Med. 2005 May;71(5):435-9. doi: 10.1055/s-2005-864139. Planta Med. 2005. PMID: 15931582

4

Genome-wide analysis of deoxyribonucleic acid in endometrial cancer using comparative genomic hybridization microarrays.

O'Toole SA, Dunn E, Sheppard BL, Klocker H, Bektic J, Smyth P, Martin C, Sheils O, O'Leary JJ. O'Toole SA, et al. Int J Gynecol Cancer. 2006 Mar-Apr;16(2):834-42. doi: 10.1111/j.1525-1438.2006.00530.x. Int J Gynecol Cancer. 2006. PMID: 16681770 Clinical Trial.

5

Potential predictors of chemotherapy response in ovarian cancer--how do we define chemosensitivity?

O'Toole SA, Sheppard BL, Laios A, O'Leary JJ, McGuinness EP, D'Arcy T, Bonnar J. O'Toole SA, et al. Gynecol Oncol. 2007 Feb;104(2):345-51. doi: 10.1016/j.ygyno.2006.08.039. Epub 2006 Oct 5. Gynecol Oncol. 2007. PMID: 17027070

6

An integrative model for recurrence in ovarian cancer.

Laios A, O'Toole SA, Flavin R, Martin C, Ring M, Gleeson N, D'Arcy T, McGuinness EP, Sheils O, Sheppard BL, O' Leary JJ. Laios A, et al. Mol Cancer. 2008 Jan 22;7:8. doi: 10.1186/1476-4598-7-8. Mol Cancer. 2008. PMID: 18211683 Free PMC article. No abstract available.

7

Altered eIF6 and Dicer expression is associated with clinicopathological features in ovarian serous carcinoma patients.

Flavin RJ, Smyth PC, Finn SP, Laios A, O'Toole SA, Barrett C, Ring M, Denning KM, Li J, Aherne ST, Aziz NA, Alhadi A, Sheppard BL, Loda M, Martin C, Sheils OM, O'Leary JJ. Flavin RJ, et al. Mod Pathol. 2008 Jun;21(6):676-84. doi: 10.1038/modpathol.2008.33. Epub 2008 Mar 7. Mod Pathol. 2008. PMID: 18327211 Free article.

8

Potential role of miR-9 and miR-223 in recurrent ovarian cancer.

Laios A, O'Toole S, Flavin R, Martin C, Kelly L, Ring M, Finn SP, Barrett C, Loda M, Gleeson N, D'Arcy T, McGuinness E, Sheils O, Sheppard B, O' Leary J. Laios A, et al. Mol Cancer. 2008 Apr 28;7:35. doi: 10.1186/1476-4598-7-35. Mol Cancer. 2008. PMID: 18442408 Free PMC article.

9

Potentially important microRNA cluster on chromosome 17p13.1 in primary peritoneal carcinoma.

Flavin RJ, Smyth PC, Laios A, O'Toole SA, Barrett C, Finn SP, Russell S, Ring M, Denning KM, Li J, Aherne ST, Sammarae DA, Aziz NA, Alhadi A, Sheppard BL, Lao K, Sheils OM, O'Leary JJ. Flavin RJ, et al. Mod Pathol. 2009 Feb;22(2):197-205. doi: 10.1038/modpathol.2008.135. Epub 2008 Aug 1. Mod Pathol. 2009. PMID: 18677302 Free article.

10

Gene expression profiling in cervical cancer: identification of novel markers for disease diagnosis and therapy.

Martin CM, Astbury K, McEvoy L, O'Toole S, Sheils O, O'Leary JJ. Martin CM, et al. Methods Mol Biol. 2009;511:333-59. doi: 10.1007/978-1-59745-447-6_15. Methods Mol Biol. 2009. PMID: 19347305

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

438 results

Search Page